FULGENT GENETICS, INC. Debt Securities, Available-for-sale, Gain (Loss)
FULGENT GENETICS, INC. (FLGT) had Debt Securities, Available-for-sale, Gain (Loss) of $400.00 thousand as of 2024-07-25, per its 10-K filed 2026-02-27.
Financial Statements › Notes
us-gaap:DebtSecuritiesAvailableForSaleGainLoss · last filed 2026-02-27
- 2024-07-25: Debt Securities, Available-for-sale, Gain (Loss) $400.00K.
| Period end | Debt Securities, Available-for-sale, Gain (Loss) |
|---|---|
| 2024-07-25 | $400.00K 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |